Scott Hammond
About Scott Hammond
Scott Hammond is the Senior Director of Product Development at Asklepios BioPharmaceutical, Inc., with over 20 years of experience in molecular and cell biology. He previously served as an Associate Professor at the University of North Carolina at Chapel Hill and has held research positions at Cold Spring Harbor Laboratory.
Work at Asklepios BioPharmaceutical
Scott Hammond serves as the Senior Director of Product Development at Asklepios BioPharmaceutical, Inc. (AskBio) since 2020. In this role, he contributes to the company's focus on advancing gene therapy products. AskBio is recognized as a clinical-stage gene therapy company, and Hammond's leadership is pivotal in driving the development of innovative therapeutic solutions.
Education and Expertise
Scott Hammond holds a Bachelor of Science in Biochemistry from San Jose State University, where he studied from 1990 to 1993. He furthered his education at Stony Brook University, earning a Doctor of Philosophy in Molecular and Cellular Pharmacology from 1994 to 1999. With over 20 years of experience in molecular and cell biology, he has developed expertise in both academic and industry settings.
Background
Prior to his current position at Asklepios BioPharmaceutical, Scott Hammond worked at the University of North Carolina at Chapel Hill as an Associate Professor from 2002 to 2020. His academic career spanned 18 years, during which he contributed to research and education in the field. Earlier in his career, he was a Postdoctoral Researcher at Cold Spring Harbor Laboratory for 9 months in 2002.
Professional Experience
Scott Hammond has extensive experience in leadership roles within both academia and the biotechnology industry. His career includes significant contributions to molecular and cell biology, particularly in the context of gene therapy. His transition from academia to industry reflects a commitment to applying scientific research to practical therapeutic applications.